Evidence map›Paper›PMID 35631111›Full record

ArticlePathogens (Basel, Switzerland)2022

Proteomic Characterization of the Oral Pathogen

Kai Bao, Rolf Claesson, Peter Gehrig, Jonas Grossmann, Jan Oscarsson, Georgios N Belibasakis

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Prevalence ofPathogens (Basel, Switzerland) · 2026
    Observational
  2. Article
  3. Article
  4. Frontiers in cellular and infection microbiology · 2026
    Article
  5. Article
  6. Prevalence of the oral pathogenFrontiers in cellular and infection microbiology · 2024
    Article
  7. Association ofFrontiers in cellular and infection microbiology · 2024
    Article
  8. The impact ofFrontiers in dental medicine · 2024
    Review
  9. Microorganisms · 2022
    Article
  10. Article
  11. Frontiers in oral health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kai BaoDivision of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, 14104 Huddinge, Sweden.
Rolf ClaessonDivision of Oral Microbiology, Department of Odontology, Umeå University, 90187 Umeå, Sweden.
Peter GehrigFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Jonas GrossmannFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.ORCID 0000-0002-6899-9020
Jan OscarssonDivision of Oral Microbiology, Department of Odontology, Umeå University, 90187 Umeå, Sweden.ORCID 0000-0002-7948-9464
Georgios N BelibasakisDivision of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, 14104 Huddinge, Sweden.ORCID 0000-0002-8164-0653

Funding

Strategic Funds from Karolinska Instiutet N/ATUA grants from Region Västerbotten, Sweden 7002667 and 7003766
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Filifactor alocisFtxAlabel-free quantification proteomics

Identifiers

PMID35631111
PMCPMC9145396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.